Totally understand what you are saying about not making assumptions Ducks. Logic would suggest, however, that it cannot simply be a sale if they are manufacturing it. That would be to say they manufacture at cost, going on the books and becoming a labour resource for BioH. You'd have to be the worst businessman that's ever lived to commit 25 years of manufacture with no margin.
But yes, if the simple words 'manufacturing revenue stream' were uttered it would likely have a material effect on the SP.
Ann: OCC Signs Striate Global License And Manufacturing Agreement, page-194
-
- There are more pages in this discussion • 105 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.5¢ |
Change
0.005(1.32%) |
Mkt cap ! $80.59M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 39.0¢ | 38.5¢ | $17.64K | 45.67K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 23269 | 38.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.5¢ | 25000 | 2 |
View Market Depth
| Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
| OCC (ASX) Chart |